Cargando…
Eucalyptus oil nanoemulsion-impregnated chitosan film: antibacterial effects against a clinical pathogen, Staphylococcus aureus, in vitro
Eucalyptus oil (Eucalyptus globulus) nanoemulsion was formulated using low-and high-energy emulsification methods. Development of nanoemulsion was optimized for system parameters such as emulsifier type, emulsifier concentration, and emulsification methods to obtain a lower droplet size with greater...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599619/ https://www.ncbi.nlm.nih.gov/pubmed/26491308 http://dx.doi.org/10.2147/IJN.S79982 |
_version_ | 1782394287555608576 |
---|---|
author | Sugumar, Saranya Mukherjee, Amitava Chandrasekaran, Natarajan |
author_facet | Sugumar, Saranya Mukherjee, Amitava Chandrasekaran, Natarajan |
author_sort | Sugumar, Saranya |
collection | PubMed |
description | Eucalyptus oil (Eucalyptus globulus) nanoemulsion was formulated using low-and high-energy emulsification methods. Development of nanoemulsion was optimized for system parameters such as emulsifier type, emulsifier concentration, and emulsification methods to obtain a lower droplet size with greater stability. The minimized droplet diameter was achieved using the high-energy method of ultrasonication. Tween 80 was more effective in reducing droplet size and emulsion appearance when compared to Tween 20. Stable nanoemulsion was formulated with Tween 80 as a surfactant, and the particle size was found to be 9.4 nm (1:2 v/v). The eucalyptus oil nanoemulsion was impregnated into chitosan (1%) as a biopolymer in varying concentrations. Further, the film was characterized by moisture content, microscopic study, X-ray diffraction, and Fourier transform infrared spectroscopy. Also, the film with and without nanoemulsion was evaluated against Staphylococcus aureus. The nanoemulsion-impregnated chitosan film showed higher antibacterial activity than chitosan film. These results support the inclusion of nanoemulsion-impregnated chitosan film in wound management studies. |
format | Online Article Text |
id | pubmed-4599619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-45996192015-10-21 Eucalyptus oil nanoemulsion-impregnated chitosan film: antibacterial effects against a clinical pathogen, Staphylococcus aureus, in vitro Sugumar, Saranya Mukherjee, Amitava Chandrasekaran, Natarajan Int J Nanomedicine Original Research Eucalyptus oil (Eucalyptus globulus) nanoemulsion was formulated using low-and high-energy emulsification methods. Development of nanoemulsion was optimized for system parameters such as emulsifier type, emulsifier concentration, and emulsification methods to obtain a lower droplet size with greater stability. The minimized droplet diameter was achieved using the high-energy method of ultrasonication. Tween 80 was more effective in reducing droplet size and emulsion appearance when compared to Tween 20. Stable nanoemulsion was formulated with Tween 80 as a surfactant, and the particle size was found to be 9.4 nm (1:2 v/v). The eucalyptus oil nanoemulsion was impregnated into chitosan (1%) as a biopolymer in varying concentrations. Further, the film was characterized by moisture content, microscopic study, X-ray diffraction, and Fourier transform infrared spectroscopy. Also, the film with and without nanoemulsion was evaluated against Staphylococcus aureus. The nanoemulsion-impregnated chitosan film showed higher antibacterial activity than chitosan film. These results support the inclusion of nanoemulsion-impregnated chitosan film in wound management studies. Dove Medical Press 2015-10-01 /pmc/articles/PMC4599619/ /pubmed/26491308 http://dx.doi.org/10.2147/IJN.S79982 Text en © 2015 Sugumar et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Sugumar, Saranya Mukherjee, Amitava Chandrasekaran, Natarajan Eucalyptus oil nanoemulsion-impregnated chitosan film: antibacterial effects against a clinical pathogen, Staphylococcus aureus, in vitro |
title | Eucalyptus oil nanoemulsion-impregnated chitosan film: antibacterial effects against a clinical pathogen, Staphylococcus aureus, in vitro |
title_full | Eucalyptus oil nanoemulsion-impregnated chitosan film: antibacterial effects against a clinical pathogen, Staphylococcus aureus, in vitro |
title_fullStr | Eucalyptus oil nanoemulsion-impregnated chitosan film: antibacterial effects against a clinical pathogen, Staphylococcus aureus, in vitro |
title_full_unstemmed | Eucalyptus oil nanoemulsion-impregnated chitosan film: antibacterial effects against a clinical pathogen, Staphylococcus aureus, in vitro |
title_short | Eucalyptus oil nanoemulsion-impregnated chitosan film: antibacterial effects against a clinical pathogen, Staphylococcus aureus, in vitro |
title_sort | eucalyptus oil nanoemulsion-impregnated chitosan film: antibacterial effects against a clinical pathogen, staphylococcus aureus, in vitro |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599619/ https://www.ncbi.nlm.nih.gov/pubmed/26491308 http://dx.doi.org/10.2147/IJN.S79982 |
work_keys_str_mv | AT sugumarsaranya eucalyptusoilnanoemulsionimpregnatedchitosanfilmantibacterialeffectsagainstaclinicalpathogenstaphylococcusaureusinvitro AT mukherjeeamitava eucalyptusoilnanoemulsionimpregnatedchitosanfilmantibacterialeffectsagainstaclinicalpathogenstaphylococcusaureusinvitro AT chandrasekarannatarajan eucalyptusoilnanoemulsionimpregnatedchitosanfilmantibacterialeffectsagainstaclinicalpathogenstaphylococcusaureusinvitro |